Agitation clinical trials

Explore recruiting agitation clinical trials.

Recruiting agitation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Agitation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimer’s Disease (ADEPT-2)

Poland, Greece, Belgium, Hungary

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated with Alzheimer’s Disease (ADAGIO-2)

Poland, Hungary, Italy, France, Czechia

Therapeutic confirmatory (Phase III) EU CTIS Study details

ADAPT: Treatment of Agitated behaviour in patients with Dementia non-responsive to guideline recommended interventions by Argued Personalised Treatment using an N-of-1 approach

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Electrophysiological analysis of Gamma-Hydroxybutyrate-induced sleep in intensive care patients: A Pilot Double-Blind Randomized Controlled Trial.(GAMMA-SLEEP)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Intravenous MELAtonin for Preventing Agitation and Emergence Delirium in children. The MELA-PAED trial: a randomized, double-blind, placebo-controlled clinical trial.

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

The PREVENT AGITATION trial II – children ≤1 year

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Agitation trials by city

Agitation in Toronto Agitation in Vancouver Agitation in Montreal Agitation in Calgary Agitation in Edmonton Agitation in Ottawa Agitation in Winnipeg Agitation in Quebec City Agitation in Hamilton Agitation in Kitchener Agitation in London Agitation in Halifax Agitation in New York Agitation in Los Angeles Agitation in Chicago Agitation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease